IO Medical Representative at Bristol-Myers Squibb

Nanjing, China

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

医、药及相关专业本科或以上学历
3年以上相关经验

Responsibilities

通过严谨、合规的产品学术推广以达成/超越区域目标
执行市场经理阐明的市场策略。从恰当的细分市场里甄别出目标HCP并与之合作，达成推广计划
充分了解所在地区和所负责区域的关键HCPs
建立和维护和关键HCP的联系，理解客户（医学）需求
达成并保持公司拜访频率、知识水平、能力、行为和个人形象方面的要求
提供给直接主管关于BMS推广材料有效性的信息
通过参加培训、会议和自学医学文献以发展和提高专业知识
和团队成员分享自己的知识和经验

Skills

Pharmaceutical Sales

HCP Engagement

Product Promotion

Market Strategy

KOL Management

Sales Targets

Medical Knowledge

Professional Training

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free